State Medicaid agencies can improve D-SNP financial transparency and reward those D-SNPs that provide the best value to ...
Synopsys SNPS shares plunged 20.8% over the past year, underperforming the Zacks Computer - Software industry, Zacks Computer ...
Synopsys (SNPS), a company that provides software for designing computer chips, is planning to sell around $10 billion worth of bonds as early ...
Synopsys (NASDAQ:SNPS – Free Report) had its price target decreased by Piper Sandler from $655.00 to $653.00 in a report released on Thursday,Benzinga reports. Piper Sandler currently has an ...
This post was written by Luke Carberry Mogan. SNPS' first-quarter performance is likely to have benefited from the rising adoption of EDA, IP solutions and Synopsys.ai platform. Get a deeper ...
Synopsys SNPS delivered better-than-expected first-quarter fiscal 2025 results. The company reported non-GAAP earnings of $3.03 per share for the first quarter, surpassing the Zacks Consensus ...
A comprehensive national study examining dementia patient outcomes for Medicare Advantage beneficiaries with Alzheimer's disease and related dementias (ADRD) uncovered key insights into healthcare ...
Despite a dip in overall revenue, Synopsys Inc (SNPS) sees growth in Design Automation and advances in AI-driven solutions.
Synopsys (NASDAQ:SNPS – Get Free Report)‘s stock had its “buy” rating restated by analysts at Needham & Company LLC in a note issued to investors on Thursday,Benzinga reports. They currently have a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback